174 related articles for article (PubMed ID: 2633575)
1. [Activity of platelet serotonin receptors of patients with endogenous depression before and after treatment with antidepressive agents].
Katasonov AB; Beliaev BS; Brusov OS; Zlobina GP; Faktor MI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(12):75-8. PubMed ID: 2633575
[TBL] [Abstract][Full Text] [Related]
2. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
[TBL] [Abstract][Full Text] [Related]
4. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
5. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
[TBL] [Abstract][Full Text] [Related]
7. Platelet serotonin markers and depressive symptomatology.
Sheline YI; Bardgett ME; Jackson JL; Newcomer JW; Csernansky JG
Biol Psychiatry; 1995 Apr; 37(7):442-7. PubMed ID: 7786957
[TBL] [Abstract][Full Text] [Related]
8. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Schins A; Hamulyák K; Scharpé S; Lousberg R; Van Melle J; Crijns H; Honig A
Life Sci; 2004 Dec; 76(6):637-50. PubMed ID: 15567189
[TBL] [Abstract][Full Text] [Related]
9. Reduction of blood platelet serotonin levels in manic and depressed patients.
Takahashi S
Folia Psychiatr Neurol Jpn; 1976; 30(4):476-86. PubMed ID: 1087914
[TBL] [Abstract][Full Text] [Related]
10. The influence of daylight exposure on platelet 5-HT levels in patients with major depression and schizophrenia.
Ljubicić D; Stipcević T; Pivac N; Jakovljević M; Mück-Seler D
J Photochem Photobiol B; 2007 Dec; 89(2-3):63-9. PubMed ID: 17937992
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of action of antidepressants and therapeutic perspectives].
Bourin M; David DJ; Jolliet P; Gardier A
Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
[TBL] [Abstract][Full Text] [Related]
12. Acute tryptophan depletion: a method of studying antidepressant action.
Miller HL; Delgado PL; Salomon RM; Licinio J; Barr LC; Charney DS
J Clin Psychiatry; 1992 Oct; 53 Suppl():28-35. PubMed ID: 1429482
[TBL] [Abstract][Full Text] [Related]
13. [Development of subsensitivity to imipramine in the system of reverse serotonin uptake by thrombocytes in patients with endogenous depression].
Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Faktor MI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(9):96-100. PubMed ID: 3232463
[TBL] [Abstract][Full Text] [Related]
14. Platelet serotonin and plasma tryptophan in depressed patients: effect of drug treatment and clinical outcome.
Karege F; Widmer J; Bovier P; Gaillard JM
Neuropsychopharmacology; 1994 May; 10(3):207-14. PubMed ID: 7916918
[TBL] [Abstract][Full Text] [Related]
15. [Reduction of platelet serotonin in major depression (endogenous depression)].
Kim HL; Plaisant O; Leboyer M; Gay C; Kamal L; Devynck MA; Meyer P
C R Seances Acad Sci III; 1982 Nov; 295(10):619-22. PubMed ID: 6819060
[TBL] [Abstract][Full Text] [Related]
16. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Ehsanullah RS
Postgrad Med J; 1980; 56 Suppl 1():31-5. PubMed ID: 7393826
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
18. Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?
Castrogiovanni P; Blardi P; De Lalla A; Dell'Erba A; Auteri A
Psychopharmacol Bull; 2003; 37(2):102-8. PubMed ID: 14566218
[TBL] [Abstract][Full Text] [Related]
19. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
20. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
Stahl S
Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
